As a result of manufacturing problems, several types of the heart drug Digoxin were recalled in 2008 and 2009, due to a risk of potentially serious injuries. The lawyers at Saiontz & Kirk are no longer investigating Digoxin Lawsuits.  The information on this page is provided for information purposes only.

Several Digoxin recalls have been issued for different brands of the popular heart drug due to manufacturing problems that allowed too much or too little of the medication to be provided in individual tablets. A recall was issued by Caraco Pharmaceutical Laboratories in March 2009 for their generic version of the drug and Actavis Totowa issued a Digitek recall in April 2008 for their brand of the same medication.

Potential Digoxin lawsuits were being reviewed for individuals who received either of the recalled heart drugs and subsequently died or required medical treatment for problems that may have been caused by a Digoxin overdose, also known as digitalis toxicity.

Symptoms of problems with an overdose could include:

  • Nausea, Vomiting and Dizziness
  • Low Blood Pressure
  • Cardiac Instability
  • Bradycardia

New cases are no longer being accepted. This page is maintained for informational purposes only.


Digoxin is a medication which requires very precise dosing.  If too little of the medication is given, it may be ineffective in treating underlying heart conditions like abnormal heart rhythms, atrial flutter, atrial fibrillation and heart failure.  If too much of the medication is provided, it may not be processed out of the body, leading to a digoxin overdose or digitalis toxicity, which could result in death.

Manufacturers have an obligation to follow certain standards established in the pharmaceutical industry to ensure that the medications they are selling provide the correct dose and correct drug that the doctor intended to prescribe.  Unfortunately, manufacturing problems and inadequate quality control efforts have recently resulted in two large Digoxin recalls.

CARACO DIGOXIN RECALL LAWSUIT:  On March 31, 2009, Caraco Pharmaceutical Laboratories, Ltd. issued a Digoxin Recall for all lots of the medication they manufactured and distributed, including Digoxini 0.125 mg (a scored round biconvex yellow tablet imprinted with “437”) and Digoxin 0.25 mg (a scored round biconvex white tablet imprinted with “441”).

>>MORE INFORMATION:  Caraco Digoxin Recall Lawsuits

DIGITEK RECALL LAWSUIT:  On April 28, 2008, Actavis Totowa issued a nationwide Digitek recall for their branded version of the generic digoxin heart drug.  Manufacturing defects allowed tablets to be distributed that could contain up to twice the appropriate amount of the medication, and reports have linked over 650 digoxin overdose deaths to potentially oversized Digitek tablets.

>>MORE INFORMATION:  Digitek Recall Lawsuits

New cases are no longer being accepted. This page is maintained for informational purposes only.